A and D vitamins and their metabolites: A new treatment for seasonal allergic rhinitis and atopy
OwnerAngelina Pinal Buttzinventor
Life of this patent
Estimating the term…
Abstract
The present invention discloses a method of treating seasonal allergic rhinitis by administering retinol and ergocalciferol to individuals suffering from a hypersensitive immunological response to an allergen. Permanent, long-term relief and prevention of the recurring symptoms of seasonal allergic rhinitis is provided by the dosages and treatment regimens described herein.
Claims10
A method of treating seasonal allergic rhinitis in an individual to thereby reduce or eliminate the hypersensitive immunological response to allergen exposure, comprising the step of:
- administering to said individual a therapeutically effective amount of retinol and ergocalciferol wherein a single dose of said retinol is from at least about 10,000 IU to about 200,000 IU and a single dose of said ergocalciferol is from at least about 50,000 IU to about 300,000 IU.
A method of treating seasonal allergic rhinitis in an individual to thereby reduce or eliminate the hypersensitive immunological response to allergen exposure, comprising the step of:
- administering to said individual an effective amount of retinol and ergocalciferol, wherein said retinol is administered in an amount of at least about 12,000 IU and said ergocalciferol is administered in an amount of at least about 60,000 IU, wherein said amount of retinol and said amount of ergocalciferol are administered orally once every 14 days to an individual weighing less than 175 pounds for a period not to exceed 6 consecutive months, wherein said amount of retinol and said amount of ergocalciferol are administered orally once every 10 days to an individual weighing over 175 pounds for a period not to exceed 6 consecutive months.
A method of treating seasonal allergic rhinitis in an individual to thereby reduce or eliminate the hypersensitive immunological response to allergen exposure, comprising the step of:
- administering to said individual an effective amount of retinol and ergocalciferol, wherein said retinol is administered in an amount of at least about 200,000 IU and said ergocalciferol is administered in an amount of at least about 300,000 IU, wherein said amount of retinol and said amount of ergocalciferol are administered orally in multiple doses for a period not to exceed 6 consecutive months.
Dependencies are inferred from the claim text.